Managed Care Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ceragenix Pharmaceuticals, Inc.
Ceragenix and Pediapharm Enter Into Distribution and Supply Agreement for EpiCeram®
March 10th, 2009
Ceragenix Pharmaceuticals, Inc. (“Ceragenix”) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology announced that it has entered into an exclusive distribution and supply agreement (the “Agreement”) with Pediapharm Inc. (“Pediapharm”), to commercialize EpiCeram®, a prescription topical cream for treating atopic dermatitis and other dry skin conditions, in Canada (the “Territory”). The Agreement grants Pediapharm exclusivity in the Territory for the distribution and marketing of EpiCeram® while Ceragenix will be responsible for the manufacturing and supply of the product. Pediapharm is also responsible for obtaining regulatory clearance to market EpiCeram® in...
Source: Managed Care Business Week (2009-03-10)
|
